Clinical trials
Phase 3 Lymphoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 6 |
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Commissie Voor Klinisch Toegepast Onderzoek | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| Lymphoma Trials Office | 2 |
| Scotland and Newcastle Lymphoma Group | 2 |
| Biovest International | 1 |
| Cairo University | 1 |
| Charite University, Berlin, Germany | 1 |
| Clatterbridge Centre for Oncology | 1 |
| Genitope Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 31 |
| Lymphoma, Follicular | 13 |
| Lymphoma, Non-Hodgkin | 10 |
| Hodgkin Disease | 8 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 8 |
| Lymphoma, B-Cell, Marginal Zone | 8 |
| Lymphoma, Large B-Cell, Diffuse | 8 |
| Lymphoma, Large-Cell, Immunoblastic | 7 |
| Lymphoma, Mantle-Cell | 7 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 7 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.